Epidemiological Characteristics of RSV
Learn more
This website contains promotional content and is intended for Healthcare Professionals

Nirsevimab Metanalysis Real world data
.webp)



The first choice of RSV prevention is Nirsevimab; alternatively, palivizumab is to be considered in case of unavailability of Nirsevimab.
